Search Results - "Ree, A H"

Season of diagnosis is a prognostic factor in Hodgkin's lymphoma: a possible role of sun-induced vitamin D by POROJNICU, A. C, ROBSAHM, T. E, REE, A. H, MOAN, J

“…Experimental studies show that vitamin D derivatives are potent anticarcinogenic factors. Epidemiological observations support this, and vitamin D sufficiency…”
Get full text

Personalized radiotherapy: concepts, biomarkers and trial design by Ree, A H, Redalen, K R

“…In the past decade, and pointing onwards to the immediate future, clinical radiotherapy has undergone considerable developments, essentially including…”
Get full text

High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases by REE, A. H, FLØRENES, V. A, BERG, J. P, MAELANDSMO, G. M, NESLAND, J. M, FODSTAD, Ø

“…Tissue inhibitors of metalloproteinases (TIMPs) are believed to possess several cellular functions, particularly the contrasting activities of inhibiting…”
Get full text

Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer by Boysen, A.K., Sørensen, B.S., Lefevre, A.C., Abrantes, R., Johansen, J.S., Jensen, B.V., Schou, J.V., Larsen, F.O., Nielsen, D., Taflin, H., Gustavson, B., Wettergren, Y., Sorensen, B.S., Ree, A.H., Dueland, S., Pallisgaard, N., Spindler, K.L.

“…Cell free DNA (cfDNA) has shown promising utility as prognostic biomarker for patients with colorectal cancer (CRC), with an ongoing need to optimize and…”
Get full text

MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer by Seierstad, T, Hole, K H, Grøholt, K K, Dueland, S, Ree, A H, Flatmark, K, Redalen, K R

“…To investigate if MRI-assessed tumour volumetry correlates with histological tumour response to neoadjuvant chemotherapy (NACT) and subsequent…”
Get full text

The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression by Bousquet, P. A., Meltzer, S., Fuglestad, A. J., Lüders, T., Esbensen, Y., Juul, H. V., Johansen, C., Lyckander, L. G., Bjørnetrø, T., Inderberg, E. M., Kersten, C., Redalen, K. R., Ree, A. H.

“…Purpose A significant percentage of colorectal cancer patients proceeds to metastatic disease. We hypothesised that mitochondrial DNA (mtDNA) polymorphisms,…”
Get full text

Expression of a novel factor in human breast cancer cells with metastatic potential by REE, A. H, TVERMYR, M, ENGEBRAATEN, O, ROOMAN, M, RØSOK, Ø, HOVIG, E, MEZA-ZEPEDA, L. A, BRULAND, Ø. S, FODSTAD, Ø

“…Clinical and experimental evidence suggests that tumor cells shed into the circulation from solid cancers are ineffective in forming distant metastasis unless…”
Get full text

Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome by Dueland, S, Ree, A.H, Grøholt, K.K, Saelen, M.G, Folkvord, S, Hole, K.H, Seierstad, T, Larsen, S.G, Giercksky, K.E, Wiig, J.N, Boye, K, Flatmark, K

“…Abstract Aims This non-randomised study was undertaken to examine oxaliplatin as possibly an intensifying component of sequential neoadjuvant therapy in…”
Get full text

Identification and Characterization of TESK2, a Novel Member of the LIMK/TESK Family of Protein Kinases, Predominantly Expressed in Testis by Røsok, Øystein, Pedeutour, Florence, Ree, Anne Hansen, Aasheim, Hans-Christian

“…In this study we present the cDNA sequence of a novel putative protein kinase, denoted TESK2. The open reading frame of TESK2 encodes a putative 555-amino-acid…”
Get full text

Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592 by Acquas, E, Carboni, E, de Ree, R H, Da Prada, M, Di Chiara, G

“…The effect of the systemic administration of a novel, orally active, catechol-O-methyltransferase (COMT) inhibitor, Ro 40-7592, on the in vivo extracellular…”
Get more information

Cellular localization of mRNAs for retinoic acid receptor-alpha, cellular retinol-binding protein, and cellular retinoic acid-binding protein in rat testis: evidence for germ cell-specific mRNAs by Eskild, W, Ree, A H, Levy, F O, Jahnsen, T, Hansson, V

“…In the present study we have examined the cellular localization and developmental changes of mRNAs for retinoid-binding proteins in rat testis. We demonstrate…”
Get full text

Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells by Ree, A H, Landmark, B F, Walaas, S I, Lahooti, H, Eikvar, L, Eskild, W, Hansson, V

“…Treatment of MCF-7 cells, a human mammary carcinoma cell line, with phorbol ester [12-O-tetradecanoylphorbol-13-acetate (TPA)] or calcium ionophore (A23187)…”
Get more information

Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: an inverse correlation to progesterone receptor levels by Ree, A H, Landmark, B F, Eskild, W, Levy, F O, Lahooti, H, Jahnsen, T, Aakvaag, A, Hansson, V

“…In the present study we have examined the effects of estradiol on mRNA levels for estrogen (ER) and progesterone receptors (PR) in the estrogen-dependent…”
Get more information

Calcium/Phospholipid-Dependent Protein Kinases in Rat Sertoli Cells: Regulation of Androgen Receptor Messenger Ribonucleic Acid by REE, A. H, HANSSON, V, WALAAS, S. I, ESKILD, W, TASKEN, K. A

“…The possibility that Sertoli cell responses to testosterone are modulated by the calcium/phospholipid-dependent protein kinase (protein kinase C; PKC) was…”
Get full text

Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells by BRATLAND, Ase, RISBERG, Karianne, FODSTAD, Øystein, REE, Anne Hansen, MAELANDSMO, Gunhild M, GÜTZKOW, Kristine Bjerve, OLSEN, Øyvind E, MOGHADDAM, Amir, WANG, Meng-Yu, HANSEN, Christina Mørk, BLOMHOFF, Heidi Kiil, BERG, Jens P

“…Tumor cells and their surrounding microenvironment produce a variety of factors that promote tumor growth and metastasis. We recently identified a nuclear…”
Get full text

Down-regulation of messenger ribonucleic acid (mRNA) for the estrogen receptor (ER) by phorbol ester requires ongoing RNA synthesis but not protein synthesis. Is hormonal control of ER mRNA degradation mediated by an RNA molecule? by Ree, A H, Knutsen, H K, Landmark, B F, Eskild, W, Hansson, V

“…Treatment of MCF-7 cells, a human mammary adenocarcinoma cell line, with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) (10-7 M) was associated…”
Get more information

Human hepatoma cells rich in P-glycoprotein display enhanced in vitro invasive properties compared to P-glycoprotein-poor hepatoma cells by Bjørnland, K, Lehne, G, Johansen, H T, Fodstad, O, Rugstad, H E, Aasen, A O, Ree, A H

“…Whether the phenotypes of drug resistance and metastatic activity in cancer are dependent on each other or not is controversial. We compared in vitro invasive…”
Get more information

Regulation of glucocorticoid receptor (GR) mRNA and protein levels by phorbol ester in MCF-7 cells. Mechanism of GR mRNA induction and decay by Ree, A H, Taskén, K, Hansson, V

“…Treatment of MCF-7 cells with the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) (10(-7) M) was associated with a time-dependent increase in specific…”
Get more information

Expression of a Novel Factor, com1, in Early Tumor Progression of Breast Cancer by Ree, A H, Pacheco, M M, Tvermyr, M, Fodstad, O, Brentani, M M

“…Tumor cells and their surrounding microenvironment produce a variety of growth factors and proteolytic enzymes to promote tumor growth and metastasis. We have…”
Get full text

Expression of matrix metalloproteinase-2 in serous borderline ovarian tumors is associated with noninvasive implant formation by Paulsen, T, Ree, A H, Kaern, J, Kjaerheim, K, Bassarova, A, Berner, A, Haldorsen, T, Tropé, C, Nesland, J M

“…To investigate matrix metalloproteinase (MMP) proteolytic and vascular endothelial growth factor (VEGF) and receptor (VEGFR-1, VEGFR-2) angiogenetic capacity…”
Get more information